Cellular functions are managed by a complex network of protein interactions, the malfunction of which may derive in disease phenotypes.
BACKGROUND
The Challenges in Computational Biology meeting (CCB) started in 2015 with the aim to bring together computational biologists based in Mainz and its surrounding area, discuss their projects and foster collaborations. In its second edition, held in 2016, CCB focused on the obstacles posed by the analysis of gene expression data and became an international meeting, with invited speakers from different european countries and Japan. Continuing the idea of having a topical programme and inspired by a compendium covering the identification, annotation and pathogenicity of protein-protein interactions (PPIs) [1] , CCB 2017 revolved around the Protein Interaction Networks and Disease subject. The workshop assembled young and expert network biologists from Europe, the UK, Israel and the US. In an enriching one-day session comprised of one company, ten invited and six contributed talks, CCB attendees discussed the current status of PPI data, of established and new tools to analyse it and the prevailing challenges in the field.
Proteins participate in every cellular process and they do so through the interaction with other proteins [2] . As a result, perturbations of one or a few members of this intricate system propagate across the protein interaction network (PIN), disturbing its dynamics and deriving in abnormal phenotypes [3] . Because of this, PINs have become the subject of intense investigation and there are several on-going projects aimed at constructing a reference, proteome-scale wiring diagram of the cell [2] .
In the meantime, computational biologists are developing tools to predict the missing pieces of this map and improve its reliability [4] . Despite their incompleteness, present-day versions of the human PIN represent an extremely valuable source of information. These PINs are being mined to predict protein function, investigate the connectivity patterns of disease-associated proteins and drug targets, analyse the relationship between diseases and find putative protein-disease associations [5] .
The scientific programme of CCB 2017 covered practically all the above-mentioned aspects not only from the computational perspective, but also from the point of view of the wet-lab. The meeting was divided in four sessions, roughly grouping talks into the topics of protein complexes and function prediction, network medicine, PPIs in neurodegenerative disorders and PIN dynamics. The following section summarises the key points covered by the speakers of the third edition of CCB.
HIGHLIGHTS Invited and company talks
CCB 2017 was opened by Prof Christine Brun from the TAGC Laboratory in France. She talked about PPI functional modules targeted by the gut bacterium F. nucleatum, as well as the detection of lncRNAs scaffolding protein complexes and their relation with disease. She was followed by Prof Volkhard Helms, from the University of Saarland in Germany, who presented his work on how the study of condition-specific and domain-level PINs leads to a more refined view Publisher: Kernel Press. Copyright c (2018) the Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
of the involvement of PPIs in haematopoiesis and cancerogenesis.
On more wet-lab oriented presentations, Dr Günter Kramer, from the Univeristy of Heidelberg in Germany, talked about the identification of co-translational PPIs of nascent protein chains via ribosome profiling. Then, Dr Bernhard Suter, from Next Interactions Inc., presented the RNA-Seq like approach that his company employs for yeast-two-hybrid PPI detection assays.
Dr Emre Guney, from the Pompeu Fabra University in Spain, talked about network-based approaches to study drug repurposing and drug effects. He also discussed proper ways to evaluate drug-drug interaction predictions (see his extended abstract in this special issue [6] ).
Dr Jörg Menche, from the CeMM in Austria, talked about how disease proteins agglomerate non-randomly in the human PIN and the effects that drug-drug interactions have on cell morphology. Dr Spyros Petrakis, from INAB/CERTH in Greece, presented a novel protein aggregation stem cell model and discussed its applications in studying the network biology of polyglutamine proteins.
Dr Ferdinando Fiumara, from the University of Turin in Italy, talked on the role of homopolymeric amino acid repeats and how they modulate the network of proteins involved in neurodegenerative diseases. Prof Roded Sharan, from the Tel Aviv University in Israel, spoke about the construction of a neurodegenerative disease PIN, its complementation with additional PPI data and the identification of disease modules through a network propagation algorithm.
In the last session, Prof Thomas Dandekar, from the University of Würzburg in Germany, presented his work on simulation of signal transduction networks via Boolean modelling. Finally, Prof Ulrich Stelzl, from the University of Graz in Austria, closed the meeting with a talk about an assay to systematically detect PPI-disruptive amino acid mutations, which represents a new way to investigate the impact of disease variation on PINs.
Contributed talks and CCB 2017 special issue
Contributed talks were selected via the peer-review of extended abstracts submitted to the present special issue. The process resulted in the selection of seven abstracts, six of which were presented at CCB. This gave both young and experimented scientists the opportunity to share and discuss their results with an international audience of network biology experts.
All contributed talks were of very high quality and introduced new ways in which PINs can be stored, analysed and integrated with other data to advance our understanding of the living cell.
Drs Birgit Meldal and Pablo Porras, molecular interaction curators at EMBL-EBI in the UK, talked about the Complex Portal and MINTAct archive, respectively. The Complex Portal is an encyclopaedic resource of macromolecular complexes derived from molecular interaction evidences extracted from the literature [7] .
The MINTAct archive is a dataset of experimentally-determined mutations affecting the interaction between a pair of proteins [8] . We anticipate that these two data sources will play a key role in future studies about the impact of protein interaction failures on human disease.
Prof Anna Niarakis, from the University of Evry in France, talked about an effort to summarise current biological knowledge about Rheumatoid Arthritis via the construction of a detailed and interactive molecular map [9] . For his part, Prof Uwe Wolfrum from the Johannes Gutenberg University of Mainz, Germany presented a high-resolution affinity proteomics strategy to identify novel VLGR1-associated protein networks [10] . This is important because mutations in the human receptor VLGR1 are associated with deaf-blindness, epilepsy and osteoporosis.
Also from Germany, Bianca Stöcker, PhD student at the University of Duisburg-Essen, introduced a model to simulate the formation of protein complexes using propositional logic to consider protein interaction constraints, such as mutual exclusion and allosteric activation [11] . Finally, Alexander Seitz, a PhD student at the University of Tübingen in Germany, presented SNPViz, a tool to highlight non-synonymous mutations in the three-dimensional structure of a protein [12] .
CONCLUSION
The rate at which high-throughput and heterogeneous molecular and medical data are being produced forecasts a data-driven future for biology and medicine [13] . In consequence, computational biology will be one of the key players in the integration, analysis and interpretation of these complex datasets.
CCB 2017 focused on the ways in which network biologists are facing the challenges posed by interactomics data. With 48 attendees from 10 different countries, the meeting highlighted the interest of young and senior researchers on the subject and, by means of an enriching programme, stimulated constructive discussions and collaboration opportunities.
We hope that the extented abstracts collected in this special issue of Genomics and Computational Biology ignite the reader's interest in Protein Interaction Networks and Disease and in future editions of CCB.
